Patient-related Predictors of Estrogen Suppression in Postmenopausal Women Using Adjuvant Letrozole
Interventional
Allocation: Non-Randomized, Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment
Change from Baseline in Serum Estradiol at day 28
baseline and day 28
No
Srikala Sridhar, MD
Principal Investigator
Mount Sinai Hospital, New York
Canada: Health Canada
AI Host Factors
NCT01669343
September 2012
Name | Location |
---|